Supernus Pharmaceuticals | SCHULD



Debt Veränderung Datum
Abbott USD 13.44B 195M 2025-06
ANI Pharmaceuticals USD 621.56M 1.26M 2025-06
Aurora Cannabis CAD 100.98M 11K 2024-12
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Canopy Growth CAD 489.67M 123.85M 2024-12
Corcept Therapeutics USD 6.6M 6.6M 2025-06
Eisai JPY 187.52B 31.58B 2025-03
Eli Lilly USD 39.9B 1.39B 2025-06
Novo Nordisk 118.72B 61.75B 2025-03
Pacira USD 580.49M 2.88M 2025-06
Perrigo USD 3.65B 24.4M 2025-06
Pfizer USD 60.93B 1.18B 2025-06
Supernus Pharmaceuticals USD 31.77M 531K 2025-06
United Therapeutics USD 200M 100M 2025-03
Xeris Pharmaceuticals USD 247.21M 15.93M 2024-12


Supernus Pharmaceuticals SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.